Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas

The clinical evaluation of chemotherapeutic agents in cancer

David A. Karnofsky · Medical Entomology and Zoology · 1949 · 2.9K citations

Medicine, Oncology, Pharmacology +14

Response criteria for phase II studies of supratentorial malignant glioma.

David R. Macdonald, T L Cascino, S. Clifford Schold et al. · Journal of Clinical Oncology · 1990 · 2.4K citations

Medicine, Oncology, Radiology +17

Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations

Anwar R. Padhani, Guoying Liu, Dow‐Mu Koh et al. · Neoplasia · 2009 · 2K citations · Full text

Medicine, Oncology, Radiology +16

Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas

Takeshi Sugahara, Yukunori Korogi, Masato Kochi et al. · Journal of Magnetic Resonance Imaging · 1999 · 1.2K citations

Medicine, Oncology, Radiology +17

Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma

James J. Vredenburgh, Annick Desjardins, James E. Herndon et al. · Clinical Cancer Research · 2007 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +17